يعرض 1 - 1 نتائج من 1 نتيجة بحث عن '"IL‐2 receptor agonist"', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1
    Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma

    المؤلفون: Murali Ravoori, Kumar Felix, Jonathan Zalevsky, Nancy Gordon, Vikas Kundra, Loui Madakamutil, Andrew Wahba, Mariella Cabrera, Marlene Hennessy, Willem W. Overwijk, Grace Kim, Rhoneil Pena, John Stewart, Maria Gabriela Segura, Saul Kivimae, Phi Quach, Eugenie S. Kleinerman, Vidya Gopalakrishnan, Vanessa B. Jensen

    المصدر: International Journal of Cancer

    مصطلحات موضوعية: Agonist, Cancer Research, Lung Neoplasms, medicine.drug_class, medicine.medical_treatment, T-Lymphocytes, Bone Neoplasms, Polyethylene Glycols, IL‐2 receptor agonist, 03 medical and health sciences, 0302 clinical medicine, Refractory, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, Medicine, Animals, Humans, Cancer Therapy and Prevention, Immune Checkpoint Inhibitors, bempegaldesleukin, Mice, Inbred BALB C, Mice, Inbred C3H, Osteosarcoma, business.industry, Effector, Growth factor, NKTR‐214, medicine.disease, Primary tumor, Survival Analysis, Blockade, Tumor Burden, Disease Models, Animal, Treatment Outcome, Oncology, Tolerability, 030220 oncology & carcinogenesis, Cancer research, Interleukin-2, Female, business, checkpoint inhibitors

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1462b9f1cebbcf8207933ddbc496ad
    http://europepmc.org/articles/PMC7984260

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء